Výsledky vyhledávání - "BMC neurology"

Upřesnit hledání
  1. 1

    Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review Autor Oliva Ramirez, Abril, Keenan, Alexander, Kalau, Olivia, Worthington, Evelyn, Cohen, Lucas, Singh, Sumeet

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 02.12.2021
    Vydáno v BMC neurology (02.12.2021)
    “…Background Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system that results in progressive and irreversible disability…”
    Získat plný text
    Journal Article
  2. 2

    Vitamin D deficiency as a risk factor for dementia and Alzheimer’s disease: an updated meta-analysis Autor Chai, Bingyan, Gao, Fulin, Wu, Ruipeng, Dong, Tong, Gu, Cheng, Lin, Qiaoran, Zhang, Yi

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 13.11.2019
    Vydáno v BMC neurology (13.11.2019)
    “…Background We aimed to comprehensively explore the associations between serum 25(OH)D deficiency and risk of dementia and Alzheimer’s disease(AD). Methods We…”
    Získat plný text
    Journal Article
  3. 3

    Reperfusion therapy in acute ischemic stroke: dawn of a new era? Autor Bhaskar, Sonu, Stanwell, Peter, Cordato, Dennis, Attia, John, Levi, Christopher

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 16.01.2018
    Vydáno v BMC neurology (16.01.2018)
    “…Following the success of recent endovascular trials, endovascular therapy has emerged as an exciting addition to the arsenal of clinical management of patients…”
    Získat plný text
    Journal Article
  4. 4

    The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageing Autor Shafto, Meredith A, Tyler, Lorraine K, Dixon, Marie, Taylor, Jason R, Rowe, James B, Cusack, Rhodri, Calder, Andrew J, Marslen-Wilson, William D, Duncan, John, Dalgleish, Tim, Henson, Richard N, Brayne, Carol, Matthews, Fiona E

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 14.10.2014
    Vydáno v BMC neurology (14.10.2014)
    “…Background As greater numbers of us are living longer, it is increasingly important to understand how we can age healthily. Although old age is often…”
    Získat plný text
    Journal Article
  5. 5

    Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations Autor Halabchi, Farzin, Alizadeh, Zahra, Sahraian, Mohammad Ali, Abolhasani, Maryam

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 16.09.2017
    Vydáno v BMC neurology (16.09.2017)
    “…Background Multiple sclerosis (MS) can result in significant mental and physical symptoms, specially muscle weakness, abnormal walking mechanics, balance…”
    Získat plný text
    Journal Article
  6. 6

    Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis Autor Fritz, Daan, van de Beek, Diederik, Brouwer, Matthijs C.

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 15.11.2016
    Vydáno v BMC neurology (15.11.2016)
    “…Background Neurosarcoidosis is a rare variant of sarcoidosis and is only described in small cohort studies. We define clinical features, treatment and outcome…”
    Získat plný text
    Journal Article
  7. 7

    Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis Autor Meyer-Moock, Sandra, Feng, You-Shan, Maeurer, Mathias, Dippel, Franz-Werner, Kohlmann, Thomas

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 25.03.2014
    Vydáno v BMC neurology (25.03.2014)
    “…Background There are a number of instruments that describe severity and progression of multiple sclerosis and they are increasingly used as endpoints to assess…”
    Získat plný text
    Journal Article
  8. 8

    Pediatric multiple sclerosis: a review Autor Alroughani, Raed, Boyko, Alexey

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 09.03.2018
    Vydáno v BMC neurology (09.03.2018)
    “…Background Pediatric-onset multiple sclerosis (POMS) prevalence and incidence rates are increasing globally. No disease-modifying therapy are approved for MS…”
    Získat plný text
    Journal Article
  9. 9

    Survival and mortality in cerebral palsy: observations to the sixth decade from a data linkage study of a total population register and National Death Index Autor Blair, Eve, Langdon, Katherine, McIntyre, Sarah, Lawrence, David, Watson, Linda

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 04.06.2019
    Vydáno v BMC neurology (04.06.2019)
    “…Background Likely duration of survival of children described as having cerebral palsy is of considerable interest to individuals with cerebral palsy, their…”
    Získat plný text
    Journal Article
  10. 10

    Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis Autor Learmonth, Yvonne C, Motl, Robert W, Sandroff, Brian M, Pula, John H, Cadavid, Diego

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 25.04.2013
    Vydáno v BMC neurology (25.04.2013)
    “…Background The Patient Determined Disease Steps (PDDS) is a promising patient-reported outcome (PRO) of disability in multiple sclerosis (MS). To date, there…”
    Získat plný text
    Journal Article
  11. 11

    The impact of physical exercise on the fatigue symptoms in patients with multiple sclerosis: a systematic review and meta-analysis Autor Razazian, Nazanin, Kazeminia, Mohsen, Moayedi, Hossein, Daneshkhah, Alireza, Shohaimi, Shamarina, Mohammadi, Masoud, Jalali, Rostam, Salari, Nader

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 13.03.2020
    Vydáno v BMC neurology (13.03.2020)
    “…Background Despite many benefits of the physical activity on physical and mental health of patients with Multiple Sclerosis (MS), the activity level in these…”
    Získat plný text
    Journal Article
  12. 12

    The misdiagnosis of prolonged disorders of consciousness by a clinical consensus compared with repeated coma-recovery scale-revised assessment Autor Wang, Jing, Hu, Xiaohua, Hu, Zhouyao, Sun, Ziwei, Laureys, Steven, Di, Haibo

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 12.09.2020
    Vydáno v BMC neurology (12.09.2020)
    “…Background Previous studies have shown that a single Coma-Recovery Scale-Revision (CRS-R) assessment can identify high rates of misdiagnosis by clinical…”
    Získat plný text
    Journal Article
  13. 13
  14. 14

    Reliability, validity, and responsiveness of three scales for measuring balance in patients with chronic stroke Autor Alghadir, Ahmad H., Al-Eisa, Einas S., Anwer, Shahnawaz, Sarkar, Bibhuti

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 13.09.2018
    Vydáno v BMC neurology (13.09.2018)
    “…Background Various outcome measures are used for the assessment of balance and mobility in patients with stroke. The purpose of the present study was to…”
    Získat plný text
    Journal Article
  15. 15

    Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study Autor Liebert, Ann, Bicknell, Brian, Laakso, E-Liisa, Heller, Gillian, Jalilitabaei, Parastoo, Tilley, Sharon, Mitrofanis, John, Kiat, Hosen

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 02.07.2021
    Vydáno v BMC neurology (02.07.2021)
    “…Background Parkinson’s disease (PD) is a progressive neurodegenerative disease with no cure and few treatment options. Its incidence is increasing due to aging…”
    Získat plný text
    Journal Article
  16. 16

    Factors associated with brain ageing - a systematic review Autor Wrigglesworth, Jo, Ward, Phillip, Harding, Ian H., Nilaweera, Dinuli, Wu, Zimu, Woods, Robyn L., Ryan, Joanne

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 12.08.2021
    Vydáno v BMC neurology (12.08.2021)
    “…Background Brain age is a biomarker that predicts chronological age using neuroimaging features. Deviations of this predicted age from chronological age is…”
    Získat plný text
    Journal Article
  17. 17

    A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine Autor Camporeale, Angelo, Kudrow, David, Sides, Ryan, Wang, Shufang, Van Dycke, Annelies, Selzler, Katherine J., Stauffer, Virginia L.

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 09.11.2018
    Vydáno v BMC neurology (09.11.2018)
    “…Background Galcanezumab, a humanized monoclonal antibody that selectively binds to the calcitonin gene-related peptide, has demonstrated in previous Phase 2…”
    Získat plný text
    Journal Article
  18. 18

    Incidence and prevalence of multiple sclerosis in Europe: a systematic review Autor Kingwell, Elaine, Marriott, James J, Jetté, Nathalie, Pringsheim, Tamara, Makhani, Naila, Morrow, Sarah A, Fisk, John D, Evans, Charity, Béland, Sarah Gabrielle, Kulaga, Sophie, Dykeman, Jonathan, Wolfson, Christina, Koch, Marcus W, Marrie, Ruth Ann

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 26.09.2013
    Vydáno v BMC neurology (26.09.2013)
    “…Background Multiple sclerosis (MS) is the most common cause of neurological disability in young adults worldwide and approximately half of those affected are…”
    Získat plný text
    Journal Article
  19. 19

    Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy Autor Adams, David, Suhr, Ole B., Dyck, Peter J., Litchy, William J., Leahy, Raina G., Chen, Jihong, Gollob, Jared, Coelho, Teresa

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 11.09.2017
    Vydáno v BMC neurology (11.09.2017)
    “…Background Patisiran is an investigational RNA interference (RNAi) therapeutic in development for the treatment of hereditary ATTR (hATTR) amyloidosis, a…”
    Získat plný text
    Journal Article
  20. 20

    Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study Autor AlJumah, Mohammed, Bunyan, R., Al Otaibi, H., Al Towaijri, G., Karim, A., Al Malik, Y., Kalakatawi, M., Alrajeh, S., Al Mejally, M., Algahtani, H., Almubarak, A., Cupler, E., Alawi, S., Qureshi, S., Nahrir, S., Almalki, A., Alhazzani, A., Althubaiti, I., Alzahrani, N., Mohamednour, E., Saeedi, J., Ishak, S., Almudaiheem, H., El-Metwally, A., Al-Jedai, A.

    ISSN: 1471-2377, 1471-2377
    Vydáno: London BioMed Central 08.02.2020
    Vydáno v BMC neurology (08.02.2020)
    “…Background In 2015, the first nationwide, multicenter Multiple Sclerosis (MS) registry was initiated in the Kingdom of Saudi Arabia (KSA) mainly with an…”
    Získat plný text
    Journal Article